Tumor cells deactivate human monocytes by up-regulating IL-1 receptor associated kinase-M expression via CD44 and TLR4

Journal of Immunology

Volumn 174, Issue 5, 2005, Pages 3032-3040

  Del Fresno, Carlos ^a   Otero, Karel ^b   Gómez García, Lourdes ^a   González Léon, Maria Carmen ^a   Soler Ranger, Llanos ^c   Fuentes Prior, Pablo ^d   Escoll, Pedro ^e   Baos, Rosa ^a   Caveda, Luis ^f   García, Felipe ^g   Arnalich, Francisco ^c   López Collazo, Eduardo ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^c UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^d Institut Català de Ciències Cardiovasculars   (Spain)

^e UNIVERSITY OF ALCALÁ   (Spain)

^f Department of Molecular Biology   (Spain)

^g Discover Unit   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BLOCKING ANTIBODY; ENDOTOXIN; HERMES ANTIGEN; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE M; INTERLEUKIN 12P40; MESSENGER RNA; PHOSPHOTRANSFERASE; SMALL INTERFERING RNA; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CELL CULTURE; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; COCULTURE; CULTURE MEDIUM; DOWN REGULATION; ENZYME ACTIVATION; HUMAN; HUMAN CELL; METASTASIS; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; SUPERNATANT; TUMOR CELL CULTURE; TUMOR CELL LINE; UPREGULATION;

EID: 20044381107     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.174.5.3032     Document Type: Article

References (49)

1. Glauser, M. P., G. Zanetti, J. D. Baumgartner, and J. Cohen. 1991. Septic shock: pathogenesis. Lancet 338:732.
2. Muñoz, C., J. Carlet, C. Fitting, B. Misset, J. P. Bleriot, and J. M. Cavaillon. 1991. Dysregulation of in vitro cytokine production by monocytes during sepsis. J. Clin. Invest. 88:1747.
3. Van Deuren, M., J. van der Ven-Jongekrijg, P. N. Demacker, A. K. Bartelink, R. van Dalen, R. W. Sauerwein, H. Gallati, J. L. Vannice, and J. W. van der Meer. 1994. Differential expression of proinflammatory cytokines and their inhibitors during the course of meningococcal infections. J. Infect. Dis. 169:157.
4. Marchant, A., M. L. Alegre, A. Hakim, G. Pierard, G. Marecaux, G. Friedman, D. De Groote, R. J. Kahn, J. L. Vincent, and M. Goldman. 1995. Clinical and biological significance of interleukin-10 plasma levels in patients with septic shock. J. Clin. Immunol. 15:266.
5. Brigati, C., D. M. Noonan, A. Albini, and R. Benelli. 2002. Tumors and inflammatory infiltrates: friends or foes? Clin. Exp. Metastasis 19:247.
6. Balkwill, F., and A. Mantovani. 2001. Inflammation and cancer: back to Virchow? Lancet 357:539.
7. Prehm, P. 1983. Synthesis of hyaluronate in differentiated teratocarcinoma cells: characterization of the synthase. Biochem. J. 211:181.
8. Kim, H. R., M. A. Wheeler, C. M. Wilson, J. Iida, D. Eng, M. A. Simpson, J. B. McCarthy, and K. M. Bullard. 2004. Hyaluronan facilitates invasion of colon carcinoma cells in vitro via interaction with CD44. Cancer Res. 64:4569.
9. Mantovani, G., A. Maccio, M. Pisano, R. Versace, P. Lai, S. Esu, E. Massa, M. Ghiani, D. Dessi, G. B. Melis, and G. S. Del Giacco. 1997. Tumor-associated lympho-monocytes from neoplastic effusions are immunologically defective in comparison with patient autologous PBMCs but are capable of releasing high amounts of various cytokines. Int. J. Cancer 71:724.
10. Sica, A., A. Saccani, B. Bottazzi, N. Polentarutti, A. Vecchi, J. Van Damme, and A. Mantovani. 2000. Autocrine production of IL-10 mediates defective IL-12 production and NF-κB activation in tumor-associated macrophages. J. Immunol. 164:762.
11. Elgert, K. D., D. G. Alleva, and D. W. Mullins. 1998. Tumor-induced immune dysfunction: the macrophage connection. J. Leukocyte Biol. 64:275.
12. Mytar, B., M. Woloszyn, R. Szatanek, M. Baj-Krzyworzeka, M. Siedlar, I. Ruggiero, J. Wieckiewicz, and M. Zembala. 2003. Tumor cell-induced deactivation of human monocytes. J. Leukocyte Biol. 74:1094.
13. Pardoll, D. 2003. Does the immune system see tumors as foreign or self? Annu. Rev. Immunol. 21:807.
14. Akira, S., and K. Takeda. 2004. Toll-like receptor signalling. Nat. Rev. Immunol. 4:499.
15. Vogel, S. N., Fitzgerald, K. A., and Fenton, M. J. 2003. TLRs: differential adapter utilization by toll-like receptors mediates TLR-specific patterns of gene expression. Mol. Interv. 3:466.
16. Akira, S., K. Takeda, and T. Kaisho. 2001. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat. Immunol. 2:675.
17. Seya, T., T. Akazawa, J. Uehori, M. Matsumoto, I. Azuma, And K. Toyoshima. 2003. Role of toll-like receptors and their adaptors in adjuvant immunotherapy for cancer. Anticancer Res. 23:4369.
18. Medvedev, A. E., A. Lentschat, L. M. Wahl, D. T. Golenbock, and S. N. Vogel. 2002. Dysregulation of LPS-induced Toll-like receptor 4-MyD88 complex formation and IL-1 receptor-associated kinase 1 activation in endotoxin-tolerant cells. J. Immunol. 169:5209.
19. Means, T. K., D. T. Golenbock, and M. J. Fenton. 2000. Structure and function of Toll-like receptor proteins. Life Sci. 68:241.
20. Medzhitov, R., P. Preston-Hurlburt, E. Kopp, A. Stadlen, C. Chen, S. Ghosh., and C. A. Janeway, Jr. 1998. MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways. Mol. Cell 2:253.
21. Suzuki, N., S. Suzuki, and W. C. Yeh. 2002. IRAK-4 as the central TIR signaling mediator in innate immunity. Trends Immunol. 23:503.
22. Jiang, Z., H. J. Johnson, H. Nie, J. Qin, T. A. Bird, and X. Li. 2003. Pellino 1 is required for interleukin-1 (IL-1)-mediated signaling through its interaction with the IL-1 receptor-associated kinase 4 (IRAK4)-IRAK-tumor necrosis factor receptor-associated factor 6 (TRAF6) complex. J. Biol. Chem. 278:10952.
23. Janeway, C. A., Jr., and R. Medzhitov. 2002. Innate immune recognition. Annu. Rev. Immunol. 20:197.
24. Muzio, M., G. Natoli, S. Saccani, M. Levrero, and A. Mantovani. 1998. The human toll signaling pathway: divergence of nuclear factor κB and JNK/SAPK activation upstream of tumor necrosis factor receptor-associated factor 6 (TRAF6). J. Exp. Med. 187:2097.
25. Wesche, H., W. J. Henzel, W. Shillinglaw, S. Li, and Z. Cao. 1997. MyD88: an adapter that recruits IRAK to the IL-1 receptor complex. Immunity 7:837.
26. Rosati, O., and M. U. Martin. 2002. Identification and characterization of murine IRAK-M. Biochem. Biophys. Res. Commun. 293:1472.
27. Mansell, A., E. Brint, J. A. Gould, L. A. O'Neill, and P. J. Hertzog. 2004. Mal interacts with TNF receptor associated factor (TRAF)-6 to mediate NF-κB activation by Toll-like receptor (TLR)-2 and TLR4. J. Biol. Chem. 279:37227.
28. Kawai, T., O. Adachi, T. Ogawa, K. Takeda, and S. Akira. 1999. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 11:115.
29. Zhang, F. X., C. J. Kirschning, R. Mancinelli, X. P. Xu, Y. Jin, E. Faure, A. Mantovani, M. Rothe, M. Muzio, and M. Arditi. 1999. Bacterial lipopolysaccharide activates nuclear factor-κB through interleukin-1 signaling mediators in cultured human dermal endothelial cells and mononuclear phagocytes. J. Biol. Chem. 274:7611.
30. Day, N., N. Tangsinmankong, H. Ochs, R. Rucker, C. Picard, J. L. Casanova, S. Haraguchi, and R. Good. 2004. Interleukin receptor-associated kinase (IRAK-4) deficiency associated with bacterial infections and failure to sustain antibody responses. J. Pediatr. 144:524.
31. Cuschieri, J., V. Bulmus, D. Gourlay, I. Garcia, A. Hoffman, P. Stayton, and R. V. Maier. 2004. Modulation of macrophage responsiveness to lipopolysaccharide by IRAK-1 manipulation. Shock 21:182.
32. Kobayashi, K., L. D. Hernandez, J. E. Galan, C. A. Janeway, Jr., R. Medzhitov, and R. A. Flavell. 2002. IRAK-M is a negative regulator of Toll-like receptor signaling. Cell 110:191.
33. Escoll, P., C. del Fresno, L. Garcia, G. Valles, M. J. Lendinez, F. Arnalich, and E. Lopez-Collazo. 2003. Rapid up-regulation of IRAK-M expression following a second endotoxin challenge in human monocytes and in monocytes isolated from septic patients. Biochem. Biophys. Res. Commun. 311:465.
34. Nakayama, K., S. Okugawa, S. Yanagimoto, T. Kitazawa, K. Tsukada, M. Kawada, S. Kimura, K. Hirai, Y. Takagaki, and Y. Ota. 2004. Involvement of IRAK-M in peptidoglycan-induced tolerance in macrophages. J. Biol. Chem. 279:6629.
35. Janssens, S., and R. Beyaert. 2003. Functional diversity and regulation of different interleukin-1 receptor-associated kinase (IRAK) family members. Mol. Cell 11:293.
36. Del Fresno, C., L. Gómez-García, L. Caveda, P. Escoll, F. Arnalich, R. Zamora, and E. López-Collazo. 2004. Nitric oxide activates the expression of IRAK-M via the release of TNF-α in human monocytes. Nitric Oxide 10:213.
37. Yabushita, H., M. Noguchi, T. Kishida, K. Fusano, Y. Noguchi, N. Itano, K. Kimata, and M. Noguchi. 2004. Hyaluronan synthase expression in ovarian cancer. Oncol. Rep. 12:739.
38. Toole, B. P. 2002. Hyaluronan promotes the malignant phenotype. Glycobiology 12:37R.
39. Toole, B. P., T. N. Wight, and M. I. Tammi. 2002. Hyaluronan-cell interactions in cancer and vascular disease. J. Biol. Chem. 1277:4593.
40. Davies, B., and S. Edwards. 1992. Interactions between human monocytes and tumour cells: monocytes can either enhance or inhibit the growth and survival of K562 cells. Brit. J. Cancer 66:463.
41. Mytar, B., M. M. Siedlar, I. Woloszyn, J. Ruggiero, A. Pryjma, and M. Zembala. 1999. Induction of reactive oxygen intermediates in human monocytes by tumour cells and their role in spontaneous monocyte cytotoxicity. Brit. J. Cancer 79:737.
42. McBride, W. H., and J. B. Bard. 1979. Hyaluronidase-sensitive halos around adherent cells: their role in blocking lymphocyte-mediated cytolysis. J. Exp. Med. 149:507.
43. Martin, T. A., G. Harrison, R. E. Mansel, and W. G. Jiang. 2003. The role of the CD44/ezrin complex in cancer metastasis. Crit. Rev. Oncol. Hemat. 46:165.
44. Yonemura, S., S. Tsukita, and S. Tsukita. 1999. Direct involvement of ezrin/radixin/moesin (ERM)-binding membrane proteins in the organization of microvilli in collaboration with activated ERM proteins. J. Cell Biol. 145:1497.
45. Sainio, M., F. Zhao, L. Heiska, O. Turunen, M. Den Bakker, E. Zwarthoff, M. Lutchman, G. A. Rouleau, J. Jaaskelainen, A. Vaheri, and O. Carpen. 1997. Neurofibromatosis 2 tumor suppressor protein colocalizes with ezrin and CD44 and associates with actin-containing cytoskeleton. J. Cell Sci. 110:2249.
46. Akisawa, N., I. Nishimori, T. Wamura, S. Onishi, and M. A. Hollingsworth. 1999. High levels of ezrin expressed by human pancreatic adenocarcinoma cell lines with high metastatic potential. Biochem. Biophys. Res. Commun. 258:395.
47. Hirao, M., N. Sato, T. Kondo, S. Yonemura, M. Monden, T. Sasaki, Y. Takai, S. Tsukita, and S. Tsukita. 1996. Regulation mechanism of ERM (ezrin/radinin/moesin) protein/plasma membrane association: possible involvement of phosphatidylinositol turnover and Rho-dependent signaling pathway. J. Cell Biol. 135:37.
48. Termeer, C., F. Benedix, J. Sleeman, C. Fieber, U. Voith, T. Ahrens, K. Miyake, M. Freudenberg, C. Galanos, and J. C. Simon. 2002. Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4. J. Exp. Med. 195:99.
49. Taylor, K. R., J. M. Trowbridge, J. A. Rudisill, C. C. Temeer, J. C. Simon, and R. L. Gallo. 2004. Hyaluronan fragments stimulate endothelial recognition of injury through TLR4. J. Biol Chem. 279:17079.